Classes
Publications
- Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy2011 | Faculty of Science
- Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases2011 | Faculty of Science
- Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA2008 | Faculty of Science
- Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH: Cytochrome P450 reductase null mouse +12008 | Faculty of Science
- The environmental pollutant and carcinogen 3-nitrobenzanthrone induces cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in rat lung and kidney, thereby enhancing its own genotoxicity2008 | Faculty of Science
- The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism2007 | Faculty of Science
- Oxidation of ellipticine by human and rat cytochromes P450 correlates with its binding to DNA2007 | Faculty of Science
- Kinetics of 3-aminobenzanthrone oxidation by rat hepatic microsomes2007 | Faculty of Science
- Comparison of the cytotoxicity of and DNA adduct formation by the anticancer drug ellipticine in human breast adenocarcinoma, leukemia and neuroblastoma cells2007 | Faculty of Science
- The effect of pH on peroxidase-mediated oxidation of and DNA adduct formation by ellipticine2006 | Faculty of Science
Loading network view...